04980nam a22005775i 4500 978-3-031-63018-7 DE-He213 20251030113252.0 cr nn 008mamaa 241031s2024 sz | s |||| 0|eng d 9783031630187 978-3-031-63018-7 10.1007/978-3-031-63018-7 doi RB127 MMBP bicssc MED093000 bisacsh MKAL thema Zacharoff, Kevin L. author. aut http://id.loc.gov/vocabulary/relators/aut 86836 Pain, Drugs, and Ethics [electronic resource] / by Kevin L. Zacharoff, Phyllis Migdal. 1st ed. 2024. Cham : Springer International Publishing : Imprint: Springer, 2024. XVI, 211 p. 1 illus. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Introduction -- Chapter 1-The Conundrum of Pain -- Chapter 2-Pain as a Disease -- Chapter 3-The Negotiation of Pain and Suffering -- Chapter 4-Biomedical and Biopsychosocial Approaches to Pain and its Management -- Chapter 5-Roles and Responsibilities of Stakeholders -- Chapter 6-Challenges Facing Clinicians Treating Patients with Pain -- Chapter 7-Dilemmas Surrounding Opioid Analgesics and the Treatment of Pain -- Chapter 8-Bias, Stigma, and Social Determinants of Healt -- Chapter 9-Ethical Decision-Making in Pain Management -- Chapter 10-Autonomy -- Chapter 11-Beneficence -- Chapter 12-Nonmaleficience -- Chapter 13-Justice -- Chapter 14-Individuality, Choice, and Paternalism in Pain Management -- Chapter 15-Ethics, Opioids, and the Overdose Epidemic -- Chapter 16-The Static Pendulum. Pain remains one of the most common reasons that people seek medical attention in the United States today. One of the ways health care providers responded to pain being designated the “5th vital sign” was with their prescription pads. In order to respond to subjective pain-ratings, opioid analgesics began to be prescribed more liberally than in the past, presumably with the intention of responding to information about pain-related complaints now captured in routine assessments. This was in concert with several other circumstances, including the appearance and promulgation of “pill mills”, questionable marketing practices by opioid manufacturers, and increasing rates of abuse, misuse, and addiction related to opioid analgesics. All this taking place in an environment of tremendous educational deficits related to pain, its assessment and treatment, and risks of aberrant drug-related behaviors. There is now a challenge to balancing the safe, compassionate, and effective treatment of chronic pain against serious negative outcomes associated with the increased abuse and misuse of these medications. With overdose death rates increasing, tensions running high, a multitude of political and regulatory involvement, and “knee-jerk” reactiveness, it seems as if the only thing being forgotten are the needs of chronic pain patients and the core ethical principles intended to help clinicians maintain the highest ethical standards of care. This book delves into this background and offers the context of professionalism and ethics taught to most healthcare professionals today, and describes how these principles can help to maximize safety, efficacy, and compassionate pain care, regardless of the direction the “opioid pendulum” is swinging. A framework is provided for clinicians to rely on best practices in managing acute, subacute, and chronic pain. The goal is to help clinicians provide patients with pain the most reliable, contextual, and ethical pain care possible. Pain, Drugs, and Ethics is written for the multiple disciplines involved in managing patients with pain today. Pain medicine. Family medicine. 63339 Primary care (Medicine). 64645 Practice of medicine. 70685 Hospitals Administration. 70686 Public health administration. 73254 Pain Medicine. General Practice and Family Medicine. 73291 Primary Care Medicine. 64645 Practice and Hospital Management. 70687 Health Administration. 73255 Migdal, Phyllis. author. aut http://id.loc.gov/vocabulary/relators/aut 86837 SpringerLink (Online service) Springer Nature eBook Printed edition: 9783031630170 Printed edition: 9783031630194 https://doi.org/10.1007/978-3-031-63018-7 ZDB-2-SME ZDB-2-SXM 64615 64615